Ahead of the Aesthetics Conference and Exhibition, journalist Allie Anderson speaks to three practitioners and ACE speakers who each discuss a case study of a patient they successfully treated with injectables
Consultant ophthalmologist Miss Elizabeth Hawkes explores the causes and treatment approaches for immediate dermal filler-related blindness
Dr Ahmed El Houssieny discusses the evidence for hyperbaric oxygen therapy in the management of vascular compromise and when the treatment may be used in practice
Dr Ahmed El Houssieny reviews the evidence for aspiration when using dermal fillers and suggests ways to minimise risk of vascular compromise
Mr Dalvi Humzah and nurse prescriber Anna Baker provide an update on forehead anatomy and review the current literature to assist with clinical practice
Research published in Scientific Reports journal has suggested that botulinum toxin (BoNT-A) could be used as an effective treatment for patients with depression.
Pharmaceutical company Croma Pharma has submitted its botulinum toxin drug file to the German Federal Institute for Drugs and Medical Devices (BfArM), for approval for the treatment of glabellar lines in the EU.